Including 35% overhead
12 cost items
For 12 participants
ANPH-150
Anessa Pharma, Inc.
Open-label, unblinded, single center, preliminary safety and efficacy study
Up to 12 participants
Note about percentages: The configured overhead rate is 35% of the base cost. In the bars, we show what percentage of the total cost each component represents (approximately 25.9% for overhead and 74.1% for base cost).
Event | Unit Cost ($) | Screening(Day -30 – Day 0) | Day1 | Day2 | Day3 | Day4 | Day5 | Week4 | EOTWeek 8 | Week9-10 | Actions |
---|---|---|---|---|---|---|---|---|---|---|---|
Informed Consent | |||||||||||
Demographics | |||||||||||
Medical History | |||||||||||
Physical Examination (including height and weight) | |||||||||||
Vital Signs | |||||||||||
Serum Pregnancy Test | |||||||||||
CBC with differential and platelets | |||||||||||
CMP Complete Metabolic Panel | |||||||||||
Shave Biopsy | |||||||||||
Study Treatment | |||||||||||
High Resolution Photography | |||||||||||
Dermatological Assessment | |||||||||||
Urinalysis | |||||||||||
PRO-CTCAE Patient Reported Outcomes | |||||||||||
Excisional Biopsy | |||||||||||
Concomitant Medications | |||||||||||
Adverse Event Monitoring | |||||||||||
Phone Call Visit with Biopsy Results | |||||||||||
Total Per Visit | $1,035 | $420 | $385 | $435 | $435 | $435 | $385 | $925 | $150 | ||
Overhead (35%) | $362 | $147 | $135 | $152 | $152 | $152 | $135 | $324 | $53 | ||
Total Per Visit with Overhead | $1,397 | $567 | $520 | $587 | $587 | $587 | $520 | $1,249 | $203 |